What happened really15 Apr 2023 14:14
It is very difficult to discuss objectively what went wrong when most shareholders here bought in the last two years, i.e.after the groundbreaking work by Cave, and mainly as a trade and not investment. The anti-viral mask was innovative, serious, and verified independently. There were problems with the mask making machine which were frankly bad luck. Who would have thought a mask making machine would not actually be able to make masks after delivery, which was protracted and primarily caused by bad luck. The mask market interest in the innovative technology was huge but through no fault of their own the Company was not able to produce the masks to satisfy the potential demand. To any objective observer It is clear that Cave and the then Board acted in good faith. The key investor, Braveheart Investment Group, being an investment business, having put the deal together with RMS (as it was then called) sold its investment at a profit as it had a duty to so do. This was a distraction to many observers and shareholders but had zero effect on the business (how could it?) though it resulted in reams of comment, most of it ill informed.
It was at this critical point of distraction that shareholders were encouraged to remove the incumbent directors and replace them with others with no relevant experience, the main attraction being they were not the previous board, and it would stop the further issue of shares which appear to have been required for a fund raise to fund the proper commercialisation of the nascent mask business.
After that the decline started, mainly because the new people had zero understanding of the strategy and ambition of their predecessors. The new board eventually had to give way to another untested team and the result it that everything pretty much that was available in January 2021 has been lost.
Pretty much all that has happened since the eviction of the original board has nothing to to with the original aims of the business. Shareholders could have sold shares for months afterwards at prices equivalent to market caps of £60-£40m, those that didn't and are here now should think hard about their reasons for staying in and ask whether their reasons are still relevant know, three, six, twelve months ago